Skip to main content
. 2017 Apr;187(4):700–712. doi: 10.1016/j.ajpath.2016.12.004

Figure 1.

Figure 1

In vivo hemodynamics assessment data on early stage (3 weeks) and late stage (6 weeks). Measurements from admittance catheter placed in the right ventricle (RV) of anesthetized rats (A–C), and a conscious, freely moving rat implanted with telemetry system transmitting real-time data from indwelling pressure-sensing catheters (D and F). A: RV systolic pressure (RVSP). B: Index of pulmonary vascular resistance [RVSP normalized by cardiac output (CO)]. C: Mean arterial pressure (MAP). D: RV pressures (systolic and diastolic). E: Systemic pressures (systolic and diastolic) and heart rate. F: Real-time RVSP tracings recorded in the telemetrically instrumented animal during VO2max testing performed at baseline (light gray line) and at 3 weeks (dark gray line) and 6 weeks (black line) after PE + SU induction. Five minutes of resting collection on a stationary treadmill belt (rest), and a 2-minute warm-up period (warm up) preceded the start (arrow) of the incremental treadmill protocol in 3-minute stages. Maximal oxygen uptake (VO2max, in mL/kg/hour), and maximal heart rate (HRmax, in bpm) are indicated in call-out boxes at each test's termination point (time to exhaustion) in addition to maximal RVSP. Values are expressed as means ± SEM (A–C). n = 4 (3 weeks; A–C); n = 4 to 6 (6 weeks; A–C). P < 0.05 versus PE + SU group; P < 0.05 versus PE group. CTEPH, chronic thromboembolic pulmonary hypertension; dSAP, diastolic–systemic arterial pressure; HR, heart rate; RVDP, RV diastolic pressure; sSAP, systolic–systemic arterial pressure.